Back to Search
JOSEPH DEJONGH, D.M.D.
General Practice Dentistry
NPI: 1619083409Individual
Specialties, Licenses & Credentials
General Practice DentistryPrimary
Dentist — General Practice
Code: 1223G0001X
DN 17082(FL)
Research & Publications (20)
Pharmacokinetics of amoxicillin in maternal, umbilical cord, and neonatal sera.
PMID 19164154·Antimicrob Agents Chemother·2009
8-other
Population pharmacokinetic model of the pregabalin-sildenafil interaction in rats: application of simulation to preclinical PK-PD study design.
PMID 19669867·Pharm Res·2009
4-observational
Morphine glucuronidation in preterm neonates, infants and children younger than 3 years.
PMID 19650676·Clin Pharmacokinet·2009
4-observational
Disease severity is a major determinant for the pharmacodynamics of propofol in critically ill patients.
PMID 17687274·Clin Pharmacol Ther·2008
4-observational
Amoxicillin pharmacokinetics in pregnant women with preterm premature rupture of the membranes.
PMID 18061131·Am J Obstet Gynecol·2008
3-trial
Pharmacokinetics of penicillin G in infants with a gestational age of less than 32 weeks.
PMID 17646418·Antimicrob Agents Chemother·2007
8-other
Application of the convection-dispersion equation to modelling oral drug absorption.
PMID 17024551·Bull Math Biol·2007
8-other
Propofol pharmacokinetics and pharmacodynamics for depth of sedation in nonventilated infants after major craniofacial surgery.
PMID 16508393·Anesthesiology·2006
8-other
Pharmacokinetics and pharmacodynamics of midazolam and metabolites in nonventilated infants after craniofacial surgery.
PMID 17122576·Anesthesiology·2006
2-rct
A mechanism-based disease progression model for comparison of long-term effects of pioglitazone, metformin and gliclazide on disease processes underlying Type 2 Diabetes Mellitus.
PMID 16552630·J Pharmacokinet Pharmacodyn·2006
8-other
Disease system analysis: basic disease progression models in degenerative disease.
PMID 16028004·Pharm Res·2005
8-other
Pharmacokinetic/pharmacodynamic modelling of the anti-hyperalgesic and anti-nociceptive effect of adenosine A1 receptor partial agonists in neuropathic pain.
PMID 15910799·Eur J Pharmacol·2005
4-observational
Population pharmacokinetic modeling of blood-brain barrier transport of synthetic adenosine A1 receptor agonists.
PMID 15292459·J Pharmacol Exp Ther·2004
7-preclinical
Population pharmacokinetic-pharmacodynamic modelling of the anti-hyperalgesic effect of 5'deoxy-N6-cylopentyladenosine in the mononeuropathic rat.
PMID 15507215·Eur J Pharmacol·2004
4-observational
Rats' performance on variable-interval schedules with a linear feedback loop between response rate and reinforcement rate.
PMID 12822684·J Exp Anal Behav·2003
7-preclinical
Population pharmacokinetic and pharmacodynamic modeling of propofol for long-term sedation in critically ill patients: a comparison between propofol 6% and propofol 1%.
PMID 12496748·Clin Pharmacol Ther·2002
3-trial
A population physiologically based pharmacokinetic/pharmacodynamic model for the inhibition of 11-beta-hydroxysteroid dehydrogenase activity by glycyrrhetic acid.
PMID 11141355·Toxicol Appl Pharmacol·2001
3-trial
Physiologically based pharmacokinetic model for tetrachlorobenzyltoluenes in rat: comparison of in vitro and in vivo metabolic rates.
PMID 11509740·Toxicol Sci·2001
4-observational
The pharmacokinetics of glycyrrhizic acid evaluated by physiologically based pharmacokinetic modeling.
PMID 11495500·Drug Metab Rev·2001
6-review
Free-operant performance on variable interval schedules with a linear feedback loop: no evidence for molar sensitivities in rats.
PMID 11056882·J Exp Psychol Anim Behav Process·2000
7-preclinical
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 1600 SW ARCHER RD, D4-4
GAINESVILLE, FL 32610 - Phone
- (352) 273-5800
Quick Facts
- NPI
- 1619083409
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile